Catch highlights from the 2019 Annual Meetings and Conferences, featuring insights and discussions, all made possible by support from Boehringer Ingelheim Pharmaceuticals.
Current Perspective on Antifibrotic Therapy for Patients with IPF
2 mins • Oct 25, 2019
Charts
This show is not currently ranked in any charts.
Recent Episodes
Oct 25, 2019
Current Perspective on Antifibrotic Therapy for Patients with IPF
2 mins
Oct 25, 2019
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (The INBUILD Trial)
2 mins
Oct 25, 2019
Goals of Care Across the Disease Continuum in IPF
3 mins
Oct 25, 2019
Emerging Diagnostic Approaches to Patients with ILD
6 mins
Oct 25, 2019
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
2 mins
Language
English
Country
United States
Categories
Website
Feed
Request an Update
Updates may take a few minutes.